At a glance
ClinicalIndex Comparison RecordN/ACompleted· 30 enrolled
Drug / intervention
etafilcon Adevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Marketed Contact Lens Real World Through Focus Curve
In Brief
A clinical study evaluating etafilcon A for Visual Acuity. Completed, enrolled 30 participants across 1 site.
Detailed Summary
This is a single-visit prospective study to establish a real world Marketed Contact Lens 'Through Focus Curve' (TFC) measurement by comparing the consistency of vision between myopes and hyperopes. 33 subjects will be enrolled (at least 15 myopes and 15 hyperopes), who are 40 years of age or older, for a 1-visit, 4-hour study for measurements to be taken.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVisual Acuity
CountriesUnited Kingdom
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartJul 2015
Primary CompletionAug 2015
First PostedFeb 2016
TodayJul 2026
First PostedFeb 11, 2016
Enrollment StartJul 1, 2015
Primary CompletionAug 1, 2015
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 10.4 years ago
Interventions
etafilcon Adevice
Marketed Multifocal Contact Lens